摘要
类风湿关节炎(rheumatoid arthritis,RA)是一种自身免疫性炎症性疾病,影响着全身多个器官和组织。随着研究新技术、新方法的出现,RA的代谢组学研究也取得了一定的进展。该文就代谢组学在RA早期生物标志物筛选、疾病发病机制等方面的应用进行综述,以期为RA的预防和诊治提供参考。
Rheumatoid arthritis is an autoimmune inflammatory rheumatism that affects many organs and tissues. With the advances in technology and research methods, the metabolomics of rheumatoid arthritis has made some progress. This article reviews the application of metabolomics in early biomarker screening and pathogenesis of rheumatoid arthritis, so as to provide reference for the prevention, diagnosis and treatment of the disease.
作者
卢靖珊
杨渐
许盈
俞昌喜
LU Jing-shan;YANG Jian;XU Ying;YU Chang-xi(College of Pharmacy, Fujian Medical University, Fuzhou 350108,China;Fujian Key Laboratory of Natural Medicine Pharmacology, College of Pharmacy, Fujian Medical University,Fuzhou 350108,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2019年第9期1193-1196,共4页
Chinese Pharmacological Bulletin
基金
国家自然科学基金面上项目(No 81872879)
福建省高校杰出青年科研人才培育计划项目(No 2017B022)
福建省自然科学基金面上项目(No 2016J01367)